Effects of an Angiotensin-Converting Enzyme Inhibitor and a β-Blocker on Cerebral Arteriolar Dilatation in Hypertensive Rats
- 1 June 2001
- journal article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 37 (6) , 1388-1393
- https://doi.org/10.1161/01.hyp.37.6.1388
Abstract
Abstract —We examined the effects of the angiotensin-converting enzyme inhibitor perindopril and the β-blocker propranolol on dilator responses of cerebral arterioles in chronic hypertension. Dilator responses to acute hypotension were examined in untreated Wistar-Kyoto rats (WKY) and stroke-prone spontaneously hypertensive rats (SHRSP) that were untreated or treated for 3 months with a low (0.3 mg · kg −1 · day −1 ) or a high (2 mg · kg −1 · day −1 ) dose of perindopril or a dose of propranolol (250 mg · kg −1 · day −1 ) alone or in combination with the low dose of perindopril. Pressure (servo-null) and diameter were measured in cerebral arterioles during acute reductions in arterial pressure both before and during maximal dilatation (EDTA). The high dose of perindopril or the combination of propranolol and perindopril normalized cerebral arteriolar pressure (52±2 [mean±SEM], 49±2 mm Hg versus 50±2 mm Hg in WKY and 96±3 mm Hg in untreated SHRSP; P <0.05). In contrast, the low dose of perindopril or propranolol alone did not normalize arteriolar pressure (74±2 mm Hg and 58±3 mm Hg). Both the low and high doses of perindopril improved autoregulatory dilatation, maximal dilatation, and dilator reserve of cerebral arterioles in SHRSP, with the low dose of perindopril being almost as effective as the high dose of perindopril. Propranolol alone did not significantly improve dilator function of cerebral arterioles. Furthermore, dilator function of cerebral arterioles was not further improved by the addition of propranolol to the low dose of perindopril. These findings suggest that angiotensin-converting enzyme inhibitors, such as perindopril, may be more effective than propranolol in attenuating the impairment of cerebral autoregulatory vasodilatation, maximal dilatation, and dilator reserve during treatment of chronic hypertension.Keywords
This publication has 18 references indexed in Scilit:
- Structure and function of resistance arteries of hypertensive patients treated with a p-blocker or a calcium channel antagonistJournal Of Hypertension, 1996
- Preservation of autoregulatory cerebral vasodilator responses to hypotension after inhibition of nitric oxide synthesisBrain Research, 1995
- Carvedilol, a new vasodilating adrenoceptor blocker antihypertensive drug, protects endothelial cells from damage initiated by xanthine-xanthine oxidase and neutrophilsCardiovascular Research, 1994
- Effects of cilazapril on cerebral vasodilatation in hypertensive rats.Hypertension, 1993
- Cerebrovascular effects of angiotensin converting enzyme inhibition involve large artery dilatation in rats.Stroke, 1991
- Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats.Hypertension, 1990
- Remodeling of cerebral arterioles in chronic hypertension.Hypertension, 1989
- Microvascular adaptation in the cerebral cortex of adult spontaneously hypertensive rats.Hypertension, 1984
- Autoregulation of Cerebral Blood Flow in Young and Aged Spontaneously Hypertensive Rats (SHR)Gerontology, 1984
- Adaptive Structural Changes of the Vascular Walls in Hypertension and their Relation to the Control of the Peripheral Resistance.Acta Physiologica Scandinavica, 1958